• AIFA registered charity 2016
  • Information for health professionals
  • Online anaphylaxis training
ASCIA News

  • Allergy testing and avoidance of allergic triggers is an important part of allergy and asthma management
    Apr 2, 2017  A media report on the Weekend Sunrise program has caused considerable confusion and misunderstanding about the role of allergy testing, with possible dangerous consequences if food allergy testing is performed without medical supervision in people at risk of severe allergic reacti...
  • Urgent TGA Medicine Recall – EpiPen 300 batches 5FA665, 5FA6651, 5FA6652, 5FA6653 (expiry April 2017)
    Apr 2, 2017  Further to the news issued on March 20, no additional batches of EpiPen® 300 adrenaline autoinjectors supplied in Australia or New Zealand have been recalled, as the most recent batches recalled were supplied in other countries.  Mar 20, 2017:   Alphapharm Pty Ltd...
  • World Allergy Week 2-8 April 2017
    Mar 8, 2017:  This is a global campaign of the World Allergy Organisation (WAO) which aims to raise awareness of the impact of allergy in our communities. This years' theme is 'The Agony of Hives – What to do when hives and swelling don’t go away'. AIFA and ASCIA (as a member society of the W...
  • AIFA grants
    Mar 8, 2017: Expressions of interest for AIFA research grants are now open and are due by 2 June 2017. Research projects previously funded by AIFA grants include Jack Jumper Ant allergy treatment, understanding FPIES and the AusPollen project. For more details about these projects visit www.aller...
  • New ASCIA website resources for health professionals - AR e-training for pharmacists, PID Clinical Update, HAE Position Paper
    Mar 3, 2017:  ASCIA allergic rhinitis (AR) e-training for pharmacists  This is the latest course that ASCIA has developed for pharmacists.  The course is available free of charge at  http://etrainingpharm.ascia.org.au/   ASCIA anaphylaxis, food allergy and allergic rhinit...
  • Possible bee venom shortage in second half of 2017
    Feb 27, 2017:  The ALK bee venom manufacturing facility recently failed a FDA inspection. ALK is therefore currently unable to supply bee venom to the US. In Australia and New Zealand the Albey brand of bee venom immunotherapy is used, which is distributed by Stallergenes Greer. The manufactu...
  • ASCIA anaphylaxis e-training for Western Australian Schools is now online
    Jan 23, 2017:  ASCIA has worked with the Western Australian Department of Health in consultation with key stakeholders to develop an anaphylaxis e-training schools course specifically for WA schools. ASCIA anaphylaxis e-training WA for schools is now available. With most Australian regions us...
  • Thunderstorm asthma epidemic
    Dec 9, 2016:  The recent thunderstorm asthma epidemic in Melbourne and its tragic consequences highlight the need for more research, education and awareness in this area. Thunderstorm asthma is thought to be triggered by thunderstorms that have rapid changes in wind, temperature and humidity,...
  • ASCIA highlights from 2016 and plans for 2017
    Nov 28, 2016:  As the end of 2016 approaches it is timely to reflect on the significant development, achievements and collaborations of ASCIA over the past year, and plans for 2017. Thank you to ASCIA members and supporters for your greatly appreciated contributions throughout 2016.  We ...
  • Allergy and Immunology Foundation of Australasia (AIFA) Research Grants
    Nov 16, 2016:  AIFA has provided $100,000 in research grants to support 6 projects over the past 3 years. This funding includes two $10,000 grants announced this month, one supporting research into Jack Jumper Ant immunotherapy and the second that will improve development of a drug for allerg...
  • AusPollen Apps for people with allergic rhinitis (hay fever) and allergic asthma
    Nov 8, 2016:  Local AusPollen Apps provide information on daily levels of pollen in the air and are currently available for Brisbane, Canberra, Melbourne and Sydney at www.pollenforecast.com.au by downloading the free App for iTunes or Google Play, and through Twitter or Facebook. Comple...
  • National Allergy Strategy - KABAM survey
    Nov 3, 2016:  THANK YOU to all who participated in the National Allergy Strategy survey for teens and young adults (KABAM survey). The response has been overwhelming and we look forward to reviewing the information to ensure we develop suitable resources for 12-24 year olds with severe allergy...
  • ASCIA 2016 Conference Report
    Sep 21, 2016:  The ASCIA 2016 conference provided more than 600 delegates with a unique opportunity to hear from 6 international experts and more than 30 local experts on a wide range of areas in allergy and clinical immunology. The conference also included 79 posters, 48 poster presentations ...
  • AIFA seed funding leads to NHMRC grant
    Aug 23, 2016:  We are proud to announce that the AusPollen project has been awarded $626,442 in the latest round of NHMRC Partnership Project grants with a further $653,129 in partner organisation in kind and cash support. AusPollen, the Australian Pollen Allergen Partnership, will build, impl...
  • Updated ASCIA Action Plans for Anaphylaxis and Allergic Reactions
    Aug 10, 2016:  ASCIA has released updated Action Plans for Anaphylaxis and Allergic Reactions on its website: www.allergy.org.au/health-professionals/anaphylaxis-resources/ascia-action-plan-for-anaphylaxis The main changes are an increased emphasis of key messages, inclusion of images to sho...
ASCIA is a WAO member society

ASCIA is a WAO member society
Follow ASCIA

ASCIA on facebookASCIA on TwitterASCIA on YouTube

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

 

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.